Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
about
Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivoMesenchymal Stem Cells after Polytrauma: Actor and TargetLysophosphatidic Acid signaling in the nervous system.The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiformeActivation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord InjuryAutotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progressionAblation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain InjuryTetracyclines increase lipid phosphate phosphatase expression on plasma membranes and turnover of plasma lysophosphatidate.Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.Promising pharmacological directions in the world of lysophosphatidic Acid signaling.Targeting lysophospholipid signaling as a therapeutic approach towards improved peripheral nerve regeneration.1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype.Plasma metabolomics profiles in rats with acute traumatic brain injury.Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson's Disease via Lysophosphatidic Acid Receptors.2-carba cyclic phosphatidic acid suppresses inflammation via regulation of microglial polarisation in the stab-wounded mouse cerebral cortex.
P2860
Q26741062-F366C336-CDAF-40F3-83F2-508909F9308DQ26747314-FBF49439-0C83-48A7-A7B4-1A0994093012Q35456340-9CB82738-73E6-44FC-845A-D90E3D063C56Q35770218-55630A67-C07C-44C8-AB61-47749C1E5696Q35851510-CF2E608E-0511-4559-B7E5-BA60BD9D5F61Q36399256-9B352769-33BE-4A0E-8F11-C517C5BFBF79Q36591218-421F99DC-A274-45AE-B595-DCBA7D05B552Q36731751-AD43E072-51E7-45C2-8863-A25CB00F1392Q36991308-3C21D512-8E1E-4B72-88EA-FF605CA676D4Q38320338-3C789596-6F8E-4227-92E2-7D27DFEA70EEQ40462969-E1E6E77A-32BC-4848-BEB8-4D05C0C0C2C7Q40960816-18B9C319-1897-4125-93DE-335F786E3DA9Q41235810-C30A2BAA-6107-4F65-AAE6-EFB2F81EE194Q47118425-40A15C57-C74D-4329-B377-E1CF86AC8ADDQ52689639-B1C4BC09-309D-4495-AABC-D65C7027C975Q55209327-AB437B91-2844-44E4-9CC7-599BE198926AQ55438711-7C796C94-22F0-4D6F-B2E4-CF15974BCB57
P2860
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
@en
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
@nl
type
label
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
@en
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
@nl
prefLabel
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
@en
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
@nl
P2093
P2860
P50
P356
P1476
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
@en
P2093
Alison Conquest
Andrew J Morris
Jonathan K Fleming
Jonathan M Wojciak
Maria Daglas
Moses Zhang
Robert L Medcalf
Roger A Sabbadini
Yona Goldshmit
P2860
P2888
P356
10.1186/1742-2094-11-37
P50
P577
2014-02-27T00:00:00Z
P5875
P6179
1041042947